Inpharma Weekly

, Volume 1560, Issue 1, pp 9–9 | Cite as

Monoclonal antibody G250 + interferon-α-2a beneficial for patients with renal cancer

Media release
  • 3 Downloads

Keywords

Survival Rate Monoclonal Antibody Interferon Median Survival Clinical Response 

Copyright information

© Adis International Ltd 2006

Personalised recommendations